FDA Inspection 853221 — Tedor Pharma, Inc.

Tedor Pharma, Inc. — FEI 3003855180

The FDA completed an inspection of Tedor Pharma, Inc. on Oct 29, 2013 in Cumberland, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 29, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cumberland, RI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.